Quantcast

Latest NewCardio Inc. Stories

2009-10-22 07:00:00

SANTA CLARA, Calif., Oct. 22 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dr. Sam George, NewCardio's Senior Consultant, will join a distinguished roster of speakers, moderators and panelists at the Cardiac Safety Research Consortium (CSRC) annual meeting in Maryland at the Marriot Bethesda, Pooks Hill location on October 29-30, 2009. Dr. George, a cardiologist, was formerly Professor of Medicine...

2009-09-18 07:00:00

SANTA CLARA, Calif., Sept. 18 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering. Gross proceeds of approximately $2.9 million were generated through the issuance of approximately 2,900 shares of a new...

2009-09-09 07:00:00

SANTA CLARA, Calif., Sept. 9 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a Top Five Clinical Research Organization (CRO), which is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a Master Services Agreement (MSA) with NewCardio. Under the terms of this agreement, the CRO will receive a license to use NewCardio's...

2009-08-27 06:00:00

SANTA CLARA, Calif., Aug. 27 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab. NewCardio expects to collaborate on the first fully automated study,...

2009-08-20 07:00:00

SANTA CLARA, Calif., Aug. 20 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that the Company has formally launched its lead product, QTinno(TM), a software suite that provides an automated, comprehensive analysis of cardiac safety for the pharmaceutical industry. NewCardio's organization has achieved organizational readiness and is now prepared to support clients effectively and efficiently as they implement...

2009-08-05 06:00:00

SANTA CLARA, Calif., Aug. 5 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dedicated Phase I, an innovative, Phoenix, Arizona-based provider of clinical research services including a Core ECG laboratory for Thorough QT and QTc studies, has signed a Master Services Agreement (MSA) with NewCardio. Under terms of this agreement, Dedicated Phase I will receive a license to use NewCardio's QTinno(TM)...

2009-07-30 06:00:00

SANTA CLARA, Calif., July 30 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-five pharmaceutical company has named NewCardio's QTinno(TM) software suite, NewCardio's first commercial product, as the technology that will be used in all of its fully automated Thorough QT (TQT) studies. The pharmaceutical company evaluated several automated cardiac safety solutions before choosing QTinno(TM) as its...

2009-07-23 07:00:00

SANTA CLARA, Calif., July 23 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Richard Brounstein, the Company's Executive Vice President and Chief Financial Officer, will present at CapStone Investments' Third Annual Small-Cap Investor Conference, to be held July 29-30, 2009, in Milwaukee at the Hyatt Regency Hotel. NewCardio is scheduled to present at 12:30 p.m. CDT on July 30, 2009. The presentation...

2009-06-16 07:00:00

Platform Technology, QTinno(TM) and Visual3Dx(TM) to be demonstrated at prestigious conference Information located at booth 238 June 21-25, 2009 SANTA CLARA, Calif., June 16 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that the Company will demonstrate the NewCardio platform, QTinno(TM) and Visual3Dx(TM) at the 45th Annual Drug Information Association (DIA) Annual Meeting from June 21-25, 2009 at the San...

2009-05-18 07:00:00

Data demonstrates that NewCardio's platform technology delivers new levels of analysis of heart's electrical activity SANTA CLARA, Calif., May 18 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that members of the Company's medical and technology teams presented two abstracts and discussed new clinical data from analytical and clinical applications of its proprietary platform technology at The Heart Rhythm...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.